Cell-free DNA as a biomarker for prostate cancer: elevated concentration and decreased fragment size
E. Chen, C. L. Cario, L. Leong, K. Lopez, C. Marquez, C. Chu, P. S. Li, E. Oropeza, I. Tenggara, J. Cowan, J. P. Simko, J. M. Chan, T. Friedlander, A. W. Wyatt, R. Aggarwal, , J. S. Witte
This study finds that higher plasma cfDNA concentrations and smaller fragment sizes are associated with more advanced prostate cancer.
bioRxiv · Jul 26, 2020 · PreprintCancer Biology